{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:57:15Z","timestamp":1760385435115,"version":"3.41.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.mehy.2015.06.011","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T21:43:47Z","timestamp":1435182227000},"page":"391-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophrenia"],"prefix":"10.1016","volume":"85","author":[{"given":"Fernando","family":"Caravaggio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Gerretsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Remington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Graff-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2015.06.011_b0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s004060070002","article-title":"Epidemiology of schizophrenia: the global burden of disease and disability","volume":"250","author":"Jablensky","year":"2000","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.mehy.2015.06.011_b0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1371\/journal.pmed.0020141","article-title":"A systematic review of the prevalence of schizophrenia","volume":"2","author":"Saha","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.mehy.2015.06.011_b0015","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.mehy.2015.06.011_b0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/schbul\/2.1.19","article-title":"The dopamine hypothesis of schizophrenia","volume":"2","author":"Meltzer","year":"1976","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.mehy.2015.06.011_b0025","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.mehy.2015.06.011_b0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archgenpsychiatry.2010.10","article-title":"Increased synaptic dopamine function in associative regions of the striatum in schizophrenia","volume":"67","author":"Kegeles","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0035","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.biopsych.2008.12.007","article-title":"Baseline and amphetamine-stimulated dopamine activity are related in drug-naive schizophrenic subjects","volume":"65","author":"Abi-Dargham","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0040","first-page":"211","article-title":"Imaging dopamine transmission in schizophrenia. A review and meta-analysis","volume":"42","author":"Laruelle","year":"1998","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.mehy.2015.06.011_b0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/schbul\/sbr180","article-title":"Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F\/(11)C]-DOPA PET studies","volume":"39","author":"Fusar-Poli","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.mehy.2015.06.011_b0050","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0055","first-page":"00152","article-title":"Examining endogenous dopamine in treated schizophrenia using [C]-(+)-PHNO positron emission tomography: a pilot study","volume":"23","author":"Caravaggio","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.mehy.2015.06.011_b0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.coph.2014.01.001","article-title":"Schizophrenia: from dopaminergic to glutamatergic interventions","volume":"14","author":"Laruelle","year":"2014","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.mehy.2015.06.011_b0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: shared and specific mechanisms","volume":"3","author":"Craft","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.mehy.2015.06.011_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1022598900246","article-title":"Brain insulin: regulation, mechanisms of action and functions","volume":"23","author":"Gerozissis","year":"2003","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.mehy.2015.06.011_b0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tem.2005.01.008","article-title":"The role of insulin receptor signaling in the brain","volume":"16","author":"Plum","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.mehy.2015.06.011_b0080","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0149-7634(00)00040-3","article-title":"Insulin receptors and insulin action in the brain: review and clinical implications","volume":"24","author":"Schulingkamp","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.mehy.2015.06.011_b0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/scnp.2003.50012","article-title":"Insulin, food intake, and reward","volume":"8","author":"Figlewicz","year":"2003","journal-title":"Semin Clin Neuropsychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0090","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.2337\/db06-0376","article-title":"Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome?","volume":"55","author":"Anthony","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2015.06.011_b0095","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.2337\/diabetes.51.12.3384","article-title":"The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study","volume":"51","author":"Bingham","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2015.06.011_b0100","first-page":"1452","article-title":"Central nervous system insulin receptors in normal and diabetic rats","volume":"105","author":"Pacold","year":"1979","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2015.06.011_b0105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/BF03349023","article-title":"Insulin receptor content in tissues of normal and diabetic rats measured by radioimmunoassay","volume":"19","author":"Pezzino","year":"1996","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.mehy.2015.06.011_b0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nn.3321","article-title":"Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids","volume":"16","author":"Labou\u00e8be","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.mehy.2015.06.011_b0115","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0031-9384(98)00233-9","article-title":"Insulin affects dopamine overflow in the nucleus accumbens and the striatum","volume":"65","author":"Potter","year":"1999","journal-title":"Physiol Behav"},{"key":"10.1016\/j.mehy.2015.06.011_b0120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tins.2007.06.004","article-title":"Is dopamine a physiologically relevant mediator of feeding behavior?","volume":"30","author":"Palmiter","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2015.06.011_b0125","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1460-9568.2012.08168.x","article-title":"Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake","volume":"36","author":"Mebel","year":"2012","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.mehy.2015.06.011_b0130","first-page":"38","article-title":"Effect of insulin on excitatory synaptic transmission onto dopamine neurons of the ventral tegmental area in a mouse model of hyperinsulinemia","volume":"16","author":"Liu","year":"2013","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.mehy.2015.06.011_b0135","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1523\/JNEUROSCI.3779-10.2011","article-title":"Insulin modulates cocaine-sensitive monoamine transporter function and impulsive behavior","volume":"31","author":"Schoffelmeer","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2015.06.011_b0140","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","article-title":"Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method","volume":"94","author":"Breier","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2015.06.011_b0145","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.6.761","article-title":"Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort","volume":"155","author":"Abi-Dargham","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0150","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81125-3","article-title":"Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance","volume":"92","author":"Kahn","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2015.06.011_b0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1043-2760(97)00031-3","article-title":"Insulin receptor knock-out mice","volume":"8","author":"Accili","year":"1997","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.mehy.2015.06.011_b0160","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/j.1460-2075.1996.tb00498.x","article-title":"Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality","volume":"15","author":"Joshi","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.mehy.2015.06.011_b0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0196-106","article-title":"Early neonatal death in mice homozygous for a null allele of the insulin receptor gene","volume":"12","author":"Accili","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.mehy.2015.06.011_b0170","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev.med.47.1.509","article-title":"Genetics of non-insulin-dependent (type-II) diabetes mellitus","volume":"47","author":"Kahn","year":"1996","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.mehy.2015.06.011_b0175","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2337\/db14-0568","article-title":"Insulin action in brain regulates systemic metabolism and brain function","volume":"63","author":"Kleinridders","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2015.06.011_b0180","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1172\/JCI29063","article-title":"Central insulin action in energy and glucose homeostasis","volume":"116","author":"Plum","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2015.06.011_b0185","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","article-title":"Role of brain insulin receptor in control of body weight and reproduction","volume":"289","author":"Br\u00fcning","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.mehy.2015.06.011_b0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0006-8993(91)91487-L","article-title":"Glucose concentrations in brain and blood: regulation by dopamine receptor subtypes","volume":"546","author":"Saller","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0028-3908(84)80005-2","article-title":"Evidence that central dopamine receptors modulate sympathetic neuronal activity to the adrenal medulla to alter glucoregulatory mechanisms","volume":"23","author":"Arneric","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2015.06.011_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126804","article-title":"The brain response to peripheral insulin declines with age: a contribution of the blood-brain barrier?","volume":"10","author":"Sartorius","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2015.06.011_b0205","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00592-013-0546-y","article-title":"Evidence for altered transport of insulin across the blood-brain barrier in insulin-resistant humans","volume":"51","author":"Heni","year":"2014","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.mehy.2015.06.011_b0210","first-page":"E331","article-title":"Relationship between plasma and cerebrospinal fluid insulin levels of dogs","volume":"233","author":"Woods","year":"1977","journal-title":"Am J Physiol"},{"key":"10.1016\/j.mehy.2015.06.011_b0215","first-page":"R200","article-title":"Penetration of peripheral glucose and insulin into cerebrospinal fluid in rats","volume":"255","author":"Steffens","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/j.mehy.2015.06.011_b0220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0149-7634(05)80004-1","article-title":"Insulin in the cerebrospinal fluid","volume":"15","author":"Plata-Salaman","year":"1991","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.mehy.2015.06.011_b0225","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1172\/JCI115431","article-title":"Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport","volume":"88","author":"Schwartz","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2015.06.011_b0230","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1172\/JCI116773","article-title":"Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain","volume":"92","author":"Baura","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2015.06.011_b0235","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0031-9384(88)90139-4","article-title":"Insulin responses and glucose levels in plasma and cerebrospinal fluid during fasting and refeeding in the rat","volume":"44","author":"Strubbe","year":"1988","journal-title":"Physiol Behav"},{"key":"10.1016\/j.mehy.2015.06.011_b0240","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2337\/diabetes.49.9.1525","article-title":"Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs","volume":"49","author":"Kaiyala","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2015.06.011_b0245","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1172\/JCI109504","article-title":"Concentrations of insulin and of insulin receptors in the brain are independent of peripheral insulin levels: studies of obese and streptozotocin-treated rodents","volume":"64","author":"Havrankova","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2015.06.011_b0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0031-9384(83)90023-9","article-title":"Influence of peripheral and intracerebroventricular glucose and insulin infusions on peripheral and cerebrospinal fluid glucose and insulin levels","volume":"30","author":"Ono","year":"1983","journal-title":"Physiol Behav"},{"key":"10.1016\/j.mehy.2015.06.011_b0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0006-8993(94)90269-0","article-title":"Dopamine depletion in nigrostriatal neurons in the genetically diabetic rat","volume":"634","author":"Kono","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0260","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0304-3940(84)90306-9","article-title":"Dopaminergic activity is reduced in diabetic rats","volume":"49","author":"Saller","year":"1984","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2015.06.011_b0265","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01249231","article-title":"Regionally-specific alterations in mesotelencephalic dopamine synthesis in diabetic rats: association with precursor tyrosine","volume":"78","author":"Bradberry","year":"1989","journal-title":"J Neural Transm Gen Sect"},{"key":"10.1016\/j.mehy.2015.06.011_b0270","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2337\/diab.32.3.222","article-title":"Effect of experimental diabetes on the levels of aromatic and branched-chain amino acids in rat blood and brain","volume":"32","author":"Crandall","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2015.06.011_b0275","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0022-3565(25)38858-0","article-title":"Diabetes-induced alteration in brain monoamine metabolism in rats","volume":"236","author":"Bitar","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mehy.2015.06.011_b0280","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1471-4159.1983.tb13590.x","article-title":"Decreased brain dopamine synthesis rate and increased [3H]spiroperidol binding in streptozotocin-diabetic rats","volume":"40","author":"Trulson","year":"1983","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2015.06.011_b0285","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF00964400","article-title":"The concentration of dopamine, 5-hydroxytryptamine, and some of their acid metabolites in the brain of genetically diabetic rats","volume":"10","author":"Kwok","year":"1985","journal-title":"Neurochem Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0290","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1159\/000124586","article-title":"Concentration of striatal tyramine and dopamine metabolism in diabetic rats and effect of insulin administration","volume":"43","author":"Kwok","year":"1986","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.mehy.2015.06.011_b0295","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0006-8993(91)90677-N","article-title":"Effects of short and long-lasting diabetes mellitus on mouse brain monoamines","volume":"552","author":"Chen","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0300","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1471-4159.1990.tb13294.x","article-title":"Effect of long-lasting diabetes mellitus on rat and human brain monoamines","volume":"54","author":"Lackovic","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2015.06.011_b0305","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF02979114","article-title":"Changes in the central dopaminergic systems in the streptozotocin-induced diabetic rats","volume":"17","author":"Lim","year":"1994","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0310","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1749-6632.2002.tb04185.x","article-title":"The competition between endogenous dopamine and radioligands for specific binding to dopamine receptors","volume":"965","author":"Cumming","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.mehy.2015.06.011_b0315","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0893-133X(97)00043-2","article-title":"Imaging D2 receptor occupancy by endogenous dopamine in humans","volume":"17","author":"Laruelle","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2015.06.011_b0320","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0893-133X(01)00231-7","article-title":"A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects","volume":"25","author":"Verhoeff","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2015.06.011_b0325","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2015.06.011_b0330","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1176\/appi.ajp.2009.08121801","article-title":"Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)\/D(3) receptors following acute dopamine depletion","volume":"166","author":"Martinez","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0335","article-title":"Reduced insulin sensitivity is related to less endogenous dopamine at D2\/3 receptors in the ventral striatum of healthy nonobese humans","volume":"25","author":"Caravaggio","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2015.06.011_b0340","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2337\/dc11-2250","article-title":"Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity","volume":"35","author":"Dunn","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2015.06.011_b0345","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/mp.2014.102","article-title":"Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior","volume":"19","author":"Guo","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0350","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/syn.21809","article-title":"Opposing relationships of BMI with BOLD and dopamine D2\/3 receptor binding potential in the dorsal striatum","volume":"69","author":"Cosgrove","year":"2015","journal-title":"Synapse"},{"key":"10.1016\/j.mehy.2015.06.011_b0355","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.biopsych.2013.02.017","article-title":"Ventral striatum binding of a dopamine D2\/3 receptor agonist but not antagonist predicts normal body mass index","volume":"77","author":"Caravaggio","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0360","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tins.2007.02.002","article-title":"Schizophrenia as a GSK-3 dysregulation disorder","volume":"30","author":"Lovestone","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2015.06.011_b0365","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jpsychires.2009.03.006","article-title":"Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia","volume":"43","author":"Bernstein","year":"2009","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2006.02.009","article-title":"Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction","volume":"84","author":"Zhao","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0375","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2015.06.011_b0380","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1176\/appi.ajp.2009.08121873","article-title":"Roles of the Akt\/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action","volume":"167","author":"Freyberg","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0385","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2007.02.006","article-title":"The Akt-GSK-3 signaling cascade in the actions of dopamine","volume":"28","author":"Beaulieu","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.mehy.2015.06.011_b0390","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1073\/pnas.1500877112","article-title":"Insulin resistance in brain alters dopamine turnover and causes behavioral disorders","volume":"112","author":"Kleinridders","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2015.06.011_b0395","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1192\/bjp.184.47.s67","article-title":"Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia","volume":"47","author":"Bushe","year":"2004","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/j.mehy.2015.06.011_b0400","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2008.04.017","article-title":"Glucose abnormalities in the siblings of people with schizophrenia","volume":"103","author":"Fernandez-Egea","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0405","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/schbul\/sbq058","article-title":"Is abnormal glucose tolerance in antipsychotic-naive patients with nonaffective psychosis confounded by poor health habits?","volume":"38","author":"Kirkpatrick","year":"2012","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.mehy.2015.06.011_b0410","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.schres.2008.09.023","article-title":"Differences in glucose tolerance between deficit and nondeficit schizophrenia","volume":"107","author":"Kirkpatrick","year":"2009","journal-title":"Schizophr Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0415","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.psychres.2013.08.056","article-title":"Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia","volume":"210","author":"Chen","year":"2013","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0420","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.schres.2006.04.010","article-title":"Higher fasting serum insulin levels are associated with a better psychopathology profile in acutely ill non-diabetic inpatients with schizophrenia","volume":"86","author":"Fan","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0425","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.schres.2012.08.034","article-title":"Diabetes is associated with lower global cognitive function in schizophrenia","volume":"142","author":"Takayanagi","year":"2012","journal-title":"Schizophr Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0430","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0435","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajp.2013.11.017","article-title":"Association between antipsychotic-induced metabolic side-effects and clinical improvement: a review on the evidence for \u201cmetabolic threshold\u201d","volume":"8","author":"Sharma","year":"2014","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.mehy.2015.06.011_b0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007999709113338","article-title":"Treatment-resistant schizophrenia\u2013the role of clozapine","volume":"14","author":"Meltzer","year":"1997","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.mehy.2015.06.011_b0445","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1176\/ajp.111.8.583","article-title":"Insulin coma therapy in schizophrenia; a fourteen-year follow-up study","volume":"111","author":"West","year":"1955","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0450","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/014107680009300313","article-title":"Insulin coma therapy in schizophrenia","volume":"93","author":"Jones","year":"2000","journal-title":"J R Soc Med"},{"key":"10.1016\/j.mehy.2015.06.011_b0455","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1192\/bjp.184.47.s64","article-title":"Diabetes mellitus and schizophrenia: historical perspective","volume":"47","author":"Kohen","year":"2004","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/j.mehy.2015.06.011_b0460","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.diabet.2008.03.003","article-title":"Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study","volume":"34","author":"Oriot","year":"2008","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.mehy.2015.06.011_b0465","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaac.2014.08.009","article-title":"Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naive patients","volume":"53","author":"Arango","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0470","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1755-5949.2010.00162.x","article-title":"All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors","volume":"17","author":"Seeman","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.mehy.2015.06.011_b0475","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1145194","article-title":"Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons","volume":"188","author":"Seeman","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.mehy.2015.06.011_b0480","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1988.01800250087012","article-title":"Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs","volume":"45","author":"Farde","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0485","doi-asserted-by":"crossref","first-page":"L103","DOI":"10.1016\/0024-3205(95)02037-J","article-title":"The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study","volume":"57","author":"Kapur","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.mehy.2015.06.011_b0490","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia","volume":"157","author":"Kapur","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0495","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1017\/S0033291700025575","article-title":"Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study","volume":"23","author":"Pilowsky","year":"1993","journal-title":"Psychol Med"},{"key":"10.1016\/j.mehy.2015.06.011_b0500","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0006-3223(01)01251-3","article-title":"Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient","volume":"50","author":"Kapur","year":"2001","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.mehy.2015.06.011_b0505","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","article-title":"Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function","volume":"75","author":"Demjaha","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0510","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","article-title":"Dopamine synthesis capacity in patients with treatment-resistant schizophrenia","volume":"169","author":"Demjaha","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0515","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.mp.4001857","article-title":"Subtyping schizophrenia: implications for genetic research","volume":"11","author":"Jablensky","year":"2006","journal-title":"Mol Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.mehy.2015.06.011_b0520","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.schres.2015.01.043","article-title":"Neuroimaging findings in treatment-resistant schizophrenia: a systematic review: lack of neuroimaging correlates of treatment-resistant schizophrenia","volume":"164","author":"Nakajima","year":"2015","journal-title":"Schizophr Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0525","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.cmet.2011.03.021","article-title":"Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis","volume":"13","author":"Konner","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.mehy.2015.06.011_b0530","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"Kapur","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2015.06.011_b0535","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.schres.2005.01.003","article-title":"From dopamine to salience to psychosis\u2013linking biology, pharmacology and phenomenology of psychosis","volume":"79","author":"Kapur","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.mehy.2015.06.011_b0540","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.euroneuro.2014.07.015","article-title":"Glutamate-mediated excitotoxicity in schizophrenia: a review","volume":"24","author":"Plitman","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.mehy.2015.06.011_b0545","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.neuropharm.2011.01.022","article-title":"GABAergic interneuron origin of schizophrenia pathophysiology","volume":"62","author":"Nakazawa","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2015.06.011_b0550","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/schbul\/sbu132","article-title":"Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation","volume":"41","author":"Salavati","year":"2015","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.mehy.2015.06.011_b0555","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2350-6-7","article-title":"Theories of schizophrenia: a genetic-inflammatory-vascular synthesis","volume":"6","author":"Hanson","year":"2005","journal-title":"BMC Med Genet"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987715002303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987715002303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:12:41Z","timestamp":1748466761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987715002303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0306987715002303"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2015.06.011","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2015.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}